Pharmacy benefit manager market concentration for prescriptions filled at US retail pharmacies

JAMA

2024-09-10

(Press-News.org) About The Study: In 2023, all 3 payer markets (commercial insurance, Medicare Part D, and Medicaid managed care) for pharmacy benefit manager (PBM) services were highly concentrated, but concentration varied and was highest in Medicare Part D. While CVS Caremark held the dominant share in all 3 payer markets, each of the PBMs appeared focused on a different payer: Express Script’s largest share was in the commercial market, while Optum Rx’s and CVS Caremark’s were in Medicare Part D and Medicaid managed care, respectively. These findings underscore the importance of considering payer-specific concentration when evaluating PBMs’ anticompetitive practices, as the 3 top PBMs may be pursuing different market strategies.

Corresponding Author: To contact the corresponding author, Dima M. Qato, PharmD, MPH, PhD, email qato@usc.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.17332)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17332?guestAccessKey=78406ce0-93f9-4de3-a404-3d1abdf4c54f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091024

END

ELSE PRESS RELEASES FROM THIS DATE:

New research shows new class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes

2024-09-10

New research published in NEJM and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that is injected once a week is as effective as daily insulin injections for effective and safe blood sugar management in patients with type 2 diabetes. The study is by Dr Carol Wysham, MultiCare Rockwood Center for Diabetes and Endocrinology, Spokane, WA, USA, and colleagues. When patients with type 2 diabetes find their oral medications alone can no longer control their blood sugar, insulin therapy is added and injection frequency (having daily injections) is among the main factors that can contribute ...

New class of weekly insulin as effective as daily injections for managing blood sugar in patients with type 1 diabetes; but higher rates of hypoglycaemia means vigilance needed (QWINT-5)

2024-09-10

New research published in The Lancet and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that only needs to be injected once weekly is as effective as daily insulin injections for effective blood sugar management in patients with type 1 diabetes. However, higher rates of hypoglycaemia using the new class means vigilance is needed for dose initiation and optimisation. The study is by Dr Richard M Bergenstal, ...

Like father, like daughter

2024-09-10

RIVERSIDE, Calif. -- When they become fathers, men who have an unhealthy, high-cholesterol diet can cause increased risk of cardiovascular disease, or CVD, in their daughters, a University of California, Riverside-led mouse study has found. The research, published in the journal JCI Insight, is the first to demonstrate this result seen only in female offspring. CVD, the leading cause of death globally, is a group of disorders that affects the heart and blood vessels. Hypertension (high blood pressure) is a leading risk factor ...

2-bromopalmitate reduces senescence in human cells: Role of palmitoylation

2024-09-10

“For the first time, the present study revealed a critical role for protein palmitoylation in the development of a DNA damage-induced senescence phenotype.” BUFFALO, NY- September 10, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 16 on August 23, 2024, entitled, “2-Bromopalmitate treatment attenuates senescence phenotype in human adult cells - possible role of palmitoylation.” As ...

Don’t judge a fossil by its teeth: despite its toothy beak, this ancient bird ate fruit, not fish

2024-09-10

For paleontologists who study animals that lived long ago, fossilized remains tell only part of the story of an animal’s life. While a well-preserved skeleton can provide hints at what an ancient animal ate or how it moved, irrefutable proof of these behaviors is hard to come by. But sometimes, scientists luck out with extraordinary fossils that preserve something beyond the animal’s body. Case in point: in a new study published in the journal Current Biology, researchers found fossilized seeds in the stomachs of one of the earliest birds. This discovery shows that these birds were eating ...

A new screening tool to improve telehealth access and equity

2024-09-10

In a new study published in JAMA Network Open, researchers at Thomas Jefferson University have developed a novel screening tool to measure digital health readiness, which will be critical in addressing barriers to telehealth adoption among diverse patient populations. The COVID-19 pandemic facilitated many rapid changes in healthcare, including a shift to using telehealth services across the U.S. instead of traditional in-person doctor’s visits. This ensured that patients continued to receive vital care, while only needing access to a mobile device or computer with a webcam. But just because a ...

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

2024-09-10

For more information, contact: Nicole Fawcett, nfawcett@umich.edu EMBARGOED for release at 11 a.m. Sept. 10, 2024 New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy ANN ARBOR, Michigan — As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study ...

Estimated health and economic outcomes of racial and ethnic tuberculosis disparities in US-born persons

2024-09-10

About The Study: In this modeling study of racial and ethnic disparities of tuberculosis (TB), these disparities were associated with substantial future health and economic outcomes of TB among U.S.-born persons without interventions beyond current efforts. Actions to eliminate disparities may reduce the excess TB burden among these persons and may contribute to accelerating TB elimination within the U.S. Corresponding Author: To contact the corresponding author, Nicole A. Swartwood, MSPH, email nswartwood@hsph.harvard.edu. To ...

Genetic analysis sheds light on the role of IFT140 in polycystic kidney disease

2024-09-10

Tokyo Medical and Dental University (TMDU) researchers uncover the genetic link in patients with polycystic kidney disease lacking family history Tokyo, Japan – Polycystic kidney disease (PKD) is an intractable disorder that causes fluid-filled cysts to grow in the kidneys. It is typically seen in adults. As one of the most prevalent hereditary kidney diseases, the autosomal dominant form of PKD is usually caused by mutations in the PKD1 and PKD2 genes. However, one out of ten patients with this condition typically exhibit no family history of the disease and lack ...

Scientists use AI to detect chronic high blood pressure in people’s voice recordings

2024-09-10

NEW YORK/TORONTO – September 10, 2024 – Researchers at Klick Labs unveiled a cutting-edge, non-invasive technique that can predict chronic high blood pressure (hypertension) with a high degree of accuracy using just a person's voice. Just published in the peer-reviewed journal IEEE Access, the findings hold tremendous potential for advancing early detection of chronic high blood pressure and showcase yet another novel way to harness vocal biomarkers for better health outcomes. The ...

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings

Pharmacy benefit manager market concentration for prescriptions filled at US retail pharmacies

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: